KYOTO, Japan--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) announced today that has successfully commercialized and mass produced "CELLNETTA," the world’s first ...
The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
We have examined the possibility that pectin solubilization and cell separation in fruit may be due to organic acids disrupting calcium bridges between pectic polysaccharides. With fruit from a wild ...
The method to be developed is intended to make the production of bioplastics simpler, cheaper and more environmentally friendly. The influence of the remaining cell residues on the material properties ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback